Literature DB >> 32369108

Association between cost-related medication nonadherence and hypertension management among US adults.

Jing Fang1, Tiffany Chang2, Guijing Wang1, Fleetwood Loustalot1.   

Abstract

BACKGROUND: Medication nonadherence is an important element of uncontrolled hypertension. Financial factors are frequently contributor to nonadherence. The objective of this study was to examine the association between cost-related medication nonadherence and self-reported antihypertensive medication use and self-reported normal blood pressure among US adults with self-reported hypertension.
METHODS: Participants with self-reported hypertension from the 2017 National Health Interview Survey were included (n=7,498). Cost-related medication nonadherence was defined using standard questions. Hypertension management included: 1) self-reported current antihypertensive medication use, and 2) self-reported normal blood pressure within the past 12 months. Adjusted prevalence and prevalence ratios of hypertension management indicators among those with and without cost-related medication non-adherence were estimated.
RESULTS: Overall, 10.7% reported cost-related medication nonadherence, 83.6% reported current antihypertensive medication use, and 67.4% reported normal blood pressure within past 12 months. Adjusted percentages of current antihypertensive medication use (88.6% vs 82.9%, p<0.001) and self-reported normal blood pressure (69.8% vs 59.5%, p=0.002) were higher among those without cost-related medication nonadherence compared to those with cost-related medication nonadherence. Adjusted prevalence ratios showed that, compared to those with cost-related medication non-adherence, those without cost-related medication non-adherence were more likely to report current antihypertensive medication use (OR=1.08, 95% confidence interval 1.04-1.12) and self-reported normal blood pressure (1.15 (1.07-1.23)).
CONCLUSIONS: Among US adults with self-reported hypertension, those without cost-related medication nonadherence were more likely to report current antihypertensive medication use and normal blood pressure within the past 12 months. Financial barriers to medication adherence persist and impact hypertension management. © American Journal of Hypertension, Ltd 2020. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Hypertension; adherence; age; antihypertensive medication use; cost-related medication non-adherence; normal blood pressure; sex

Year:  2020        PMID: 32369108     DOI: 10.1093/ajh/hpaa072

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  The influence of the pandemic on fear of contagion, blood pressure management and adherence to medication in hypertensive older adults in Turkey.

Authors:  Ayşegül Özcan; İlknur Aydın Avcı
Journal:  J Hum Hypertens       Date:  2022-07-18       Impact factor: 2.877

2.  Opinions on hypertension care and therapy adherence at the healthcare provider and healthcare system level: a qualitative study in the Hague, Netherlands.

Authors:  Saskia E van Grondelle; Sytske van Bruggen; Judith Meijer; Erik van Duin; Michiel L Bots; Guy Rutten; Hedwig M M Vos; Mattijs E Numans; Rimke C Vos
Journal:  BMJ Open       Date:  2022-07-08       Impact factor: 3.006

Review 3.  Advancing Equity in Blood Pressure Control: A Response to the Surgeon General's Call-to-Action.

Authors:  Calvin L Colvin; Ayoola Kalejaiye; Gbenga Ogedegbe; Yvonne Commodore-Mensah
Journal:  Am J Hypertens       Date:  2022-03-08       Impact factor: 3.080

Review 4.  Cost-Effectiveness of Recommendations From the Surgeon General's Call-to-Action to Control Hypertension.

Authors:  Gabriel S Tajeu; Stavros Tsipas; Michael Rakotz; Gregory Wozniak
Journal:  Am J Hypertens       Date:  2022-03-08       Impact factor: 3.080

5.  Cost-Related Antihypertensive Medication Nonadherence: Action in the Time of COVID-19 and Beyond.

Authors:  Gabriel S Tajeu; Paul Muntner
Journal:  Am J Hypertens       Date:  2020-09-10       Impact factor: 2.689

Review 6.  State-of-the-Art review: Hypertension practice guidelines in the era of COVID-19.

Authors:  Keith C Ferdinand; Thanh N Vo; Melvin R Echols
Journal:  Am J Prev Cardiol       Date:  2020-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.